Ixiaro
NDC 62195-051, Japanese Encephalitis Vaccine, Inactivated, Adsorbed, injection, suspension, from Vetter Pharma Fertigung GmbH & Co. KG.
- Product NDC
- 62195-051
- Status
- Listed
- Labeler
- Vetter Pharma Fertigung GmbH & Co. KG
- Dosage form
- INJECTION, SUSPENSION
- Route
- INTRAMUSCULAR
- Product type
- VACCINE
- Marketing category
- BLA
- Application
- BLA125280
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/62195-051 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- JAPANESE ENCEPHALITIS VIRUS STRAIN SA 14-14-2 ANTIGEN (FORMALDEHYDE INACTIVATED)6 ug/.5mL
Pharmacologic classes
Actively Acquired Immunity [PE]; Inactivated Japanese Encephalitis Virus Vaccine [EPC]; Japanese Encephalitis Vaccines [CS]; Vaccines, Inactivated [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 62195-051-01 | 62195005101 | .5 mL in 1 SYRINGE (62195-051-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 62195-051 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/62195-051 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 62195-051. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.